Leveraging Technology to Develop New Trial Endpoints

December 17, 2018 Bill Byrom

Originally published in Applied Clinical Trials - December 2018. Click on the article image below to read.

This article reviews the "future endpoints" session chaired by Bill Byrom at this year's DIA Annual Meeting.  Bill reviews the use of wearable sensors to measure EEG activity to derive objective measures of pain; published work by researchers at Roche exploring the use of new endpoints based on remotely administered performance tests conducted using smartphones in MS patients; and work using consumer depth cameras such as Microsoft Kinect to develop new objective measures of movement.

Previous Article
Different, Not Less: Why We Need to Ensure Clinical Research is Patient-Driven
Different, Not Less: Why We Need to Ensure Clinical Research is Patient-Driven

In honor of Autism Awareness Month, we spoke with Brian Catton, PharmD, who he sheds light on Autism and aw...

Next Article
Leveraging Today's Gaming For Better Health Reported Outcomes Tomorrow - ICDVRAT 2018
Leveraging Today's Gaming For Better Health Reported Outcomes Tomorrow - ICDVRAT 2018

Researchers from across the world collaborated to review work developing applications using immersive and m...